Blastemal predominant WT1 negative Wilms tumour of the young adult: a unique case report and review of the literature
Status PubMed-not-MEDLINE Language English Country Switzerland Media electronic-ecollection
Document type Case Reports, Journal Article
PubMed
40177273
PubMed Central
PMC11961890
DOI
10.3389/fmed.2025.1507011
Knihovny.cz E-resources
- Keywords
- WT1 negative, Wilms tumour, adult, blastemal predominant, case report, nephroblastoma, renal,
- Publication type
- Journal Article MeSH
- Case Reports MeSH
Wilms tumour is a common juvenile cancer of the kidney, and its occurrence in adolescence or adulthood is extremely rare, accounting for around 1% of all adult kidney malignancies. Histopathologically, three tissue patterns can be identified, including blastemal, epithelial, and stromal components, while the overall microscopic appearance of an adult-type tumour does not differ from that of its juvenile counterpart. The blastemal predominant Wilms tumours are the most aggressive and have the worst prognosis. The samples must be histopathologically verified before the definitive diagnosis can be made, and immunohistochemistry examination is critical. Wilms tumours are often positive for keratin, vimentin, desmin, actin, and WT1, which distinguishes this type of tumour from other malignancies. WT1 positivity is indicative of the blastemal component of the tumorous tissue and may be completely absent in the mature epithelial and stromal parts. Only three WT1 negative adult-type Wilms tumours have been reported in the literature to this date. However, none of the patients had a blastemal predominant tumour. That is why we would like to present a highly interesting and diagnostically challenging case of a young man who was diagnosed with a tumorous lesion of the left kidney parenchyma. Genetic analysis did not reveal any known fusion genes associated with round cell sarcomas, ruling out this differential diagnosis. This article also includes a literature review on published articles on WT1 negative Wilms tumour in adults and other concerns related to this topic. The main goal of this publication was to emphasise that, while it is a rare entity in general, similar problematic cases can occur in practise, and thus it is important to be aware of this type of tumour when making a differential diagnosis in cases with similar clinical and histopathological features.
Bioptical Laboratory Ltd Pilsen Czechia
Department of Imaging Methods Faculty of Medicine University of Ostrava Ostrava Czechia
Department of Pathology EUC Laboratoře CGB a s Ostrava Czechia
Department of Pathology Faculty Hospital Olomouc Olomouc Czechia
Department of Pathology Faculty of Medicine and Dentistry Palacky University Olomouc Olomouc Czechia
Department of Pathology Faculty of Medicine Charles University Plzen Czechia
Department of Radiology University Hospital Ostrava Ostrava Czechia
Department of Surgery University Hospital Ostrava Ostrava Czechia
Department of Surgical Studies Faculty of Medicine Ostrava University Ostrava Czechia
Department of Urology University Hospital Ostrava Ostrava Czechia
See more in PubMed
Mounnarath ET, Zwieky W, Aedo-Lopez V, Fazli O, Sheridan BJ. Adult Wilms tumour: a case report. SAGE Open Med Case Rep. (2022) 10:2050313X221097265. doi: 10.1177/2050313X221097265, PMID: PubMed DOI PMC
Farzadnia M, Karrabi M, Ghorbani H. Adult Wilms with biphasic pattern; a case report. Casp J Intern Med. (2021) 12:S421–5. doi: 10.22088/cjim.12.0.421 PubMed DOI PMC
Spreafico F, Ferrari A, Mascarin M, Collini P, Morosi C, Biasoni D, et al. . Wilms tumor, medulloblastoma, and rhabdomyosarcoma in adult patients: lessons learned from the pediatric experience. Cancer Metastasis Rev. (2019) 38:683–94. doi: 10.1007/s10555-019-09831-3, PMID: PubMed DOI
Al-Hussain T, Ali A, Akhtar M. Wilms tumor: an update. Adv Anat Pathol. (2014) 21:166–73. doi: 10.1097/PAP.0000000000000017, PMID: PubMed DOI
Diniz G. Histopathological and molecular characteristics of Wilms tumor. In: Heuvel-Eibrink MM, editor. Wilms tumor. Brisbane (AU): Codon Publications; (2016). Available online at: http://www.ncbi.nlm.nih.gov/books/NBK373356/ PubMed
Huszno J, Starzyczny-Słota D, Jaworska M, Nowara E. Adult Wilms’ tumor—diagnosis and current therapy. Cent Eur J Urol. (2013) 65:39–44. doi: 10.5173/ceju.2013.01.art12, PMID: PubMed DOI PMC
Hu J, Jin LU, He T, Li Y, Zhao Y, Ding YU, et al. . Wilms’ tumor in a 51-year-old patient: An extremely rare case and review of the literature. Mol Clin Oncol. (2016) 4:1013–6. doi: 10.3892/mco.2016.839, PMID: PubMed DOI PMC
Vallejo Yepes C, Bermudez M, Camacho-Nieto D, Mesa J, Bruges R. Adult Wilms’ tumor: case report and literature review. Cureus. (2021) 13:e15524. doi: 10.7759/cureus.15524, PMID: PubMed DOI PMC
Modi S, Tiang KW, Inglis P, Collins S. Adult Wilms’ tumour: case report and review of literature. J Kidney Cancer VHL. (2016) 3:1–7. doi: 10.15586/jkcvhl.2016.52, PMID: PubMed DOI PMC
Patnayak R, Rambabu DVS, Jena A, Vijaylaxmi B, Phaneendra BV, Reddy MK. Rare case of blastemal predominant adult Wilms’ tumor with skeletal metastasis case report and brief review of literature. Indian J Urol IJU J Urol Soc India. (2012) 28:447–9. doi: 10.4103/0970-1591.105772, PMID: PubMed DOI PMC
Sghiri T. Adult Wilms? Tumour: a rare presentation of two case reports with review of literature. J Clin Case Rep. (2013) 3:03. doi: 10.4172/2165-7920.1000277, PMID: PubMed DOI
Trivedi S, Reddy KS, Yadav M, Agrawal LK, Kumar U, Singh Y. A rare case of adult Wilms tumor: case report and literature review from a tertiary Centre. Int Surg J. (2021) 8:3176–9. doi: 10.18203/2349-2902.isj20214019 DOI
Sánchez González Á, Salguero S, Dos S, Carrasco V, Martínez L, Burgos R, et al. . Case report on adult Wilms’ Tumor and Review of the Literature. Int Arch Urol Complicat. (2019) 5:5. doi: 10.23937/2469-5742/1510060, PMID: PubMed DOI
Tripathi S, Mishra A, Popat VC, Husain SA. Wilms’ tumor in adults-conventional and unconventional presentations of a rare entity with a review of literature. J Kidney Cancer VHL. (2021) 8:40–8. doi: 10.15586/jkcvhl.v8i2.186, PMID: PubMed DOI PMC
Kadota N, Hatakeyama N, Hino H, Kunishige M, Kondo Y, Okano Y, et al. . Complete and durable response of pulmonary large-cell neuroendocrine carcinoma to pembrolizumab. Cancer Rep Hoboken NJ. (2022) 5:e1589. doi: 10.1002/cnr2.1589, PMID: PubMed DOI PMC
Goyal S, Mishra K, Sarkar U, Sharma S, Kumari A. Diagnostic utility of Wilms’ tumour-1 protein (WT-1) immunostaining in paediatric renal tumours. Indian J Med Res. (2016) 143:S59–67. doi: 10.4103/0971-5916.191776, PMID: PubMed DOI PMC
Lenci N, Francesco P, Scarciglia E, Fiorentino V, Schino M, Palermo G, et al. . Metanephric adenoma with BRAF V600K mutation and a doubtful radiological imaging: pitfalls in the diagnostic process. Med Mol Morphol. (2021) 54:187–91. doi: 10.1007/s00795-020-00269-z, PMID: PubMed DOI PMC
Yin X, Zhang X, Pan X, Tan J, Zheng L, Zhou Q, et al. . Atypical metanephric adenoma: shares similar histopathological features and molecular changes of metanephric adenoma and epithelial-predominant Wilms’ tumor. Front Oncol. (2022) 12:12. doi: 10.3389/fonc.2022.1020456 PubMed DOI PMC
Hastie ND. Wilms’ tumour 1 (WT1) in development, homeostasis and disease. Dev Camb Engl. (2017) 144:2862–72. doi: 10.1242/dev.153163, PMID: PubMed DOI
Schumacher V, Schuhen S, Sonner S, Weirich A, Leuschner I, Harms D, et al. . Two molecular subgroups of Wilms’ tumors with or without WT1 mutations. Clin Cancer Res Off J Am Assoc Cancer Res. (2003) 9:2005–14. PubMed
Sugiyama H. WT1 (Wilms’ tumor gene 1): biology and cancer immunotherapy. Jpn J Clin Oncol. (2010) 40:377–87. doi: 10.1093/jjco/hyp194, PMID: PubMed DOI
Parenti R, Perris R, Vecchio GM, Salvatorelli L, Torrisi A, Gravina L, et al. . Immunohistochemical expression of Wilms’ tumor protein (WT1) in developing human epithelial and mesenchymal tissues. Acta Histochem. (2013) 115:70–5. doi: 10.1016/j.acthis.2012.04.006, PMID: PubMed DOI
Dome JS, Graf N, Geller JI, Fernandez CV, Mullen EA, Spreafico F, et al. . Advances in Wilms tumor treatment and biology: Progress through international collaboration. J Clin Oncol Off J Am Soc Clin Oncol. (2015) 33:2999–3007. doi: 10.1200/JCO.2015.62.1888, PMID: PubMed DOI PMC
Kinney SN, Eble JN, Hes O, Williamson SR, Grignon DJ, Wang M, et al. . Metanephric adenoma: the utility of immunohistochemical and cytogenetic analyses in differential diagnosis, including solid variant papillary renal cell carcinoma and epithelial-predominant nephroblastoma. Mod Pathol Off J U S Can Acad Pathol Inc. (2015) 28:1236–48. doi: 10.1038/modpathol.2015.81, PMID: PubMed DOI
Argani P, Tickoo SK, Matoso A, Pratilas CA, Mehra R, Tretiakova M, et al. . Adult Wilms tumor: genetic evidence of origin of a subset of cases from Metanephric adenoma. Am J Surg Pathol. (2022) 46:988–99. doi: 10.1097/PAS.0000000000001864, PMID: PubMed DOI PMC
Wegert J, Vokuhl C, Collord G, Del Castillo V-HM, Farndon SJ, Guzzo C, et al. . Recurrent intragenic rearrangements of EGFR and BRAF in soft tissue tumors of infants. Nat Commun. (2018) 9:2378. doi: 10.1038/s41467-018-04650-6, PMID: PubMed DOI PMC
Szychot E, Apps J, Pritchard-Jones K. Wilms’ tumor: biology, diagnosis and treatment. Transl Pediatr. (2014) 3:12–24. doi: 10.3978/j.issn.2224-4336.2014.01.09, PMID: PubMed DOI PMC
Perlman EJ, Faria P, Soares A, Hoffer F, Sredni S, Ritchey M, et al. . Hyperplastic perilobar nephroblastomatosis: long-term survival of 52 patients. Pediatr Blood Cancer. (2006) 46:203–21. doi: 10.1002/pbc.20386, PMID: PubMed DOI
Kinoshita Y, Ikeda T, Miyamura T, Ueda Y, Yoshida Y, Ueda M, et al. . Nodular pulmonary amyloidosis associated with Sjögren’s syndrome. Intern Med. (2022) 61:877–81. doi: 10.2169/internalmedicine.8169-21, PMID: PubMed DOI PMC
Huang X, Wu J, Xiao Y, Zhang Y. Timing of plasma exchange for neuromyelitis optica spectrum disorders: a meta-analysis. Mult Scler Relat Disord. (2021) 48:102709. doi: 10.1016/j.msard.2020.102709, PMID: PubMed DOI
Bai YF, Niu JQ, Shangguan JY, Liang JJ, Wu XH, Wang W, et al. . Asymptomatic adult Wilms’ tumor: a case report. Radiol Case Rep. (2022) 17:2802–5. doi: 10.1016/j.radcr.2022.04.039, PMID: PubMed DOI PMC